Ambulance Stretchers Market: Understanding Consumer Preferences and Needs

 The global ambulance stretchers market was valued at USD 2.22 billion in 2023 and is anticipated to reach USD 2.82 billion by 2030, growing at a CAGR of 3.5% from 2024 to 2030. The increasing geriatric population and the rising prevalence of chronic diseases drive a greater demand for emergency medical services. This demographic change significantly boosts the need for ambulance stretchers, as older adults frequently require urgent medical care.

Additionally, the rise in road accidents highlights the necessity for effective ambulance stretchers that ensure timely and efficient patient transport, emphasizing the importance of innovation in stretcher design and functionality. The incorporation of telemedicine features and the development of electric-powered and lightweight models improve the efficiency and safety of patient transport, responding to the demand for enhanced care during emergencies.

Moreover, the post-pandemic emphasis on healthcare has underlined the need for well-equipped ambulances capable of safely transporting patients, especially those with infectious diseases. This trend has led to an increased focus on eco-friendly stretcher designs aimed at minimizing waste and carbon footprints, reflecting a broader commitment to sustainability within the healthcare sector. As healthcare systems continue to progress, the demand for advanced ambulance stretchers that fulfill the needs of both patients and healthcare providers is expected to grow.

Key Market Trends & Insights

• North America ambulance stretchers market dominated the global market in 2023 with a revenue share of 30.5% due to established healthcare systems, technological advancements, and high healthcare spending. Moreover, the increasing occurrence of accidents and chronic illnesses in the area also enhances the need for ambulance stretchers.

• U.S. ambulance stretchers market dominated the North America market with a share of 78.7% in 2023. The U.S. boasts a comprehensive healthcare infrastructure, including hospitals and ambulance services, generating a substantial demand for advanced ambulance stretchers.

• By product, transport stretchers segment dominated the market and accounted for a share of 55.0% in 2023. Transport stretchers are designed for non-emergency patient transfers within healthcare facilities, prioritizing comfort, convenience, and mobility. These stretchers often feature collapsible frames, locking mechanisms, and ergonomic designs, simplifying movement and reducing the burden on healthcare professionals.

• By technology, manual stretchers segment accounted for the largest market revenue share of 45.4% in 2023, the extensive product offerings from leading manufacturers and their lightweight, portable design, making them suitable for use in remote locations.

• By equipment, hospitals dominated the market and accounted for a share of 41.9% in 2023. The need for efficient patient transport within hospitals and between healthcare facilities is driving the adoption of advanced ambulance stretchers.

Order a free sample PDF of the Ambulance Stretchers Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 2.22 Billion
• 2030 Projected Market Size: USD 2.82 Billion
• CAGR (2024-2030): 3.5%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Some key companies in ambulance stretchers market include Stryker; Baxter; Medline Industries, LP.; Narang Medical Limited; FU SHUN HSING

TECHNOLOGY CO., LTD; and others. The market players are dedicating significant resources to research and development, driving the introduction of innovative features and technologies that enhance patient safety and comfort during transportation.

• FU SHUN HSING TECHNOLOGY CO., LTD is a manufacturer of innovative medical equipment, including 40 medical transport stretchers and hospital beds. The company’s product range encompasses transfer trolleys, stretchers, lights, and beds for various medical settings, including specialized products for pediatric care. They also offer customizable solutions through OEM and ODM services.

• Ferno-Washington, Inc. is a manufacturer of emergency, mortuary, and healthcare solutions. The company’s comprehensive product range includes ambulance cots, stair chairs, restraints, mattresses, and stretcher accessories, catering to the needs of various healthcare professionals.

Key Players
• Stryker
• Baxter
• Medline Industries, LP.
• Narang Medical Limited
• FU SHUN HSING TECHNOLOGY CO., LTD
• Ferno-Washington, Inc.
• Zhangjiagang New Fellow Med Co.,Ltd.
• ROYAX
• MAC Medical, Inc.
• Advanced Instrumentations

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

Global ambulance stretchers market growth is driven by an increasing geriatric population and a rise in chronic diseases, which heighten the demand for emergency medical services. The prevalence of road accidents further underscores the need for effective stretcher designs, incorporating innovations like telemedicine capabilities and lightweight models for improved patient transport. Additionally, the post-pandemic focus on healthcare emphasizes the importance of well-equipped ambulances, leading to a trend towards eco-friendly stretcher designs that align with sustainability goals. As healthcare systems evolve, the demand for advanced ambulance stretchers is expected to rise.

AI In Life Science Analytics Market: Driving Innovation and Discovery

 The global market for AI in life science analytics was valued at USD 1,731.7 million in 2023 and is expected to grow to USD 3,608.1 million by 2030, reflecting a CAGR of 10.9% from 2024 to 2030. This significant growth is fueled by advancements in AI and machine learning technologies, which have improved the analysis of complex, large-scale datasets, resulting in enhanced drug discovery, personalized medicine, and patient care.

Moreover, increased investments from pharmaceutical companies and government initiatives that promote AI research and development are further driving market growth. AI’s ability to streamline clinical trials, optimize supply chain management, and enhance decision-making processes is accelerating its adoption in the life sciences sector.

Industries within life sciences concentrate on improving health through innovative medical solutions, including drug development, treatments for critical diseases, and minimally invasive surgical tools that enhance patient outcomes and recovery times. Companies are actively pursuing AI innovation in this field. For instance, in October 2023, Fujitsu Limited and RIKEN's HPC- and AI-driven Drug Development Platform Division unveiled a new AI technology capable of predicting protein structural changes from electron microscope images, generating 3D density maps using generative AI.

Key Market Trends & Insights

• In terms of region, North America was the largest revenue generating market in 2023.
• In terms of segment, cloud accounted for a revenue of USD 1,731.7 million in 2023.
• Cloud is the most lucrative delivery segment registering the fastest growth during the forecast period.

Order a free sample PDF of the AI In Life science Analytics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 1,731.7 Million
• 2030 Projected Market Size: USD 3,608.1 Million
• CAGR (2024-2030): 10.9%
• North America: Largest market in 2023

Key Companies & Market Share Insights

The market is extremely competitive, with many companies globally investing in AI-based tools to deliver more effective analytical solutions. For instance, in September 2021, IQVIA introduced the AI-driven MI Contact Center for life sciences. This solution allows companies to disseminate information via new virtual agents, working alongside human experts to prioritize and address inquiries more efficiently.

Key Players

• Indegene
• Lexalytics
• Databricks
• SAS Institute, Inc.
• IQVIA
• IBM
• Sorcero
• Axtria

Browse Horizon Databook for Global AI In Life science Analytics Market Size & Outlook

Conclusion

AI in life science analytics market growth is driven by advancements in AI and machine learning, enhancing drug discovery, personalized medicine, and patient care. Increased investments from pharmaceutical companies and government support for AI research are also contributing to this expansion. Additionally, AI streamlines clinical trials and optimizing supply chain management. Notably, Fujitsu Limited and RIKEN recently introduced AI technology that predicts protein structural changes from electron microscope images, showcasing ongoing innovation in this sector.

Absorbable Sutures Market: Future Outlook and Strategic Developments

 The global absorbable sutures market was valued at approximately USD 2.9 billion in 2024 and is anticipated to grow to USD 3.9 billion by 2030, with a compound annual growth rate (CAGR) of 5.3% from 2025 to 2030. This growth is fuelled by several factors, including the rising demand for minimally invasive surgeries and advancements in suture technology. The trend towards less invasive procedures facilitates quicker recovery and fewer complications, leading to increased utilization of absorbable sutures across various medical fields such as general surgery, Orthopedics, and ophthalmology. Innovations in suture materials, which enhance tensile strength and biocompatibility, are also driving market expansion.

Absorbable sutures are designed to dissolve gradually in the body, negating the need for removal. They are constructed from bioabsorbable materials such as polyglycolic acid (PGA), polylactic acid (PLA), polyglactin, and polydioxanone (PDO). These sutures offer numerous benefits, including reduced patient discomfort, lowered infection risk, and faster recovery times.

A significant factor contributing to market growth is the increasing volume of surgical procedures worldwide. The World Federation of Neurology reports that 12.0% of total neurology patients die from various conditions annually. Additionally, Medico Experts indicates that 22.6 million individuals experience neurological injuries, with 13.8 million requiring surgical intervention. The World Health Organization (WHO) projects that the number of Disability-Adjusted Life Years (DALYs) lost to neurological diseases will rise from 95 million in 2015 to 103 million by 2030 globally. This surge in neurological surgeries and the heightened demand for specially designed absorbable sutures are expected to further propel market growth.

Key Market Trends & Insights

• The North America absorbable sutures market led globally, securing 32.9% of the revenue share in 2024. According to the American Hospital Association Statistics 2024, there are approximately 6,120 operational hospitals in the U.S., conducting 40–50 million surgeries each year for conditions such as cardiovascular diseases, cancer, and trauma (NCBI, 2020).

• The Asia Pacific absorbable sutures market is experiencing rapid growth due to the increase in chronic diseases like cancer, diabetes, and cardiovascular conditions, especially in China, India, and Japan. With 1.4 million cancer diagnoses reported in India in 2022, the demand for advanced surgical tools is rising.

• By product type, the needled absorbable sterilized sutures segment held the largest revenue share at 80.9% in 2024 and is projected to grow at the fastest CAGR during the forecast period. These sutures come pre-attached to a needle, ensuring accurate and efficient application across various surgeries, including general, cardiovascular, and orthopedic procedures.

• In terms of filament type, the multifilament segment accounted for the largest revenue share of 57.0% in 2024, owing to its enhanced strength, flexibility, and ease of handling. Comprised of multiple intertwined threads, multifilament sutures offer superior knot security and are less prone to slipping during procedures.

• Regarding application, the cardiac surgery segment was the leading area in the absorbable sutures market, capturing the largest revenue share of 26.7% in 2024, driven by the high demand for heart-related surgical procedures. Absorbable sutures play a vital role in cardiac surgeries for closing incisions and securing tissue, eliminating the need for removal, which reduces patient discomfort and infection risk.

• By end use, the hospitals & clinics segment dominated the market, accounting for the largest revenue share of 44.1% in 2024. These healthcare facilities are the primary settings where absorbable sutures are extensively used in various surgical procedures, including general, orthopedic, and cardiovascular surgeries.

Order a free sample PDF of the Absorbable Sutures Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 2.9 Billion
• 2030 Projected Market Size: USD 3.9 Billion
• CAGR (2025-2030): 5.3 %
• North America: Largest market in 2024

Key Companies & Market Share Insights

The global absorbable sutures industry is characterized by intense competition, with major players like Johnson & Johnson, B Braun Melsungen AG, and Teleflex Incorporated occupying prominent positions. These leading companies are implementing a range of strategies, both organic and inorganic, including new product development, collaborations, acquisitions, mergers, and regional expansion, to address the unmet needs of their customers.

Key Players

• Johnson & Johnson
• Teleflex Incorporated
• B Braun Melsungen AG
• DemeTECH Corporation
• Lotus Surgicals Pvt Ltd
• Teleflex Incorporated
• Integra Lifesciences Corporation
• Healthium Medtech (formerly Suture India)
• Samyang Holdings Corporation
• Internacional Farmacéutica S.A. de C.V. (Atramat)

Browse Horizon Databook for Global Absorbable Sutures Size & Outlook

Conclusion

The global absorbable sutures market growth is driven by increasing demand for minimally invasive surgeries and advancements in suture technology, which promote quicker recovery and fewer complications. Absorbable sutures, made from bioabsorbable materials like PGA and PLA, dissolve gradually in the body, eliminating the need for removal and reducing patient discomfort and infection risk.

The rising number of surgical procedures worldwide significantly contributes to market expansion. Reports indicate a substantial incidence of neurological conditions, with millions requiring surgical intervention. The WHO forecasts an increase in Disability-Adjusted Life Years (DALYs) lost to neurological diseases, further driving the demand for absorbable sutures in surgical applications.